RP-L102
RP-L102-0418
Phase 2 mab active
Quick answer
RP-L102 for Fanconi Anemia Complementation Group A is a Phase 2 program (mab) at Rocket Pharmaceuticals B.V. with 3 ClinicalTrials.gov record(s).
Program details
- Company
- Rocket Pharmaceuticals B.V.
- Indication
- Fanconi Anemia Complementation Group A
- Phase
- Phase 2
- Modality
- mab
- Status
- active